Skip to content

A Study on Symptom Trajectories and Influencing Factors of Adverse Reactions to Subcutaneous Injection of Targeted Drugs in Breast Cancer Patients from the Perspective of Health Ecology

A Study on Symptom Trajectory and Influencing Factors of Adverse Reactions to Subcutaneous Injection of Targeted Drugs for Breast Cancer from the Health Ecology Perspective

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117959
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-01-31
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Case group:None

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1. Female; 2. Aged >=18years; 3. Pathologically confirmed as breast cancer (Stage ?–?); 4. Patients receiving subcutaneous injection of targeted drugs; 5. Able to complete symptom diary and telephone follow-up independently or with assistance; 6. Clear consciousness, without mental disorders or communication barriers;

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1. Complicated with severe systemic infection, severe anemia or failure of vital organ functions; 2. A history of breast cancer or other types of malignancies within the past 5 years; 3. Distant tumor metastasis during the treatment course;

Design outcomes

Primary

MeasureTime frame
symptom;

Secondary

MeasureTime frame
depression;Anxiety;Baseline, Cycle 1 (1 day before injection, 24 hours after injection, Day 3 after injection, Day 14 after injection), Cycle 2, Cycle 3, and subsequent cycles until the completion of treatment.; Personality;

Countries

China

Contacts

Public ContactLiu Chunmei

Tianjin Medical University Cancer Institute and Hospital

fish8373@163.com+86 23 340 123 6417

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026